|
|
||||||||
Original Research |
Metabolic Bone Diseases Unit (E.S., S.I.-S.), ISRAEL
Endocrine Laboratory, (B.R.), ISRAEL
Department of Clinical Nutrition (G.S.R.), ISRAEL
Rambam Medical Center, Gastroenterology Unit, Bnei Zion Medical Center (A.L.), ISRAEL
Department of Community Medicine and Epidemiology, Carmel Medical Center (A.T.), ISRAEL
The Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology (A.T., S.I.-S.), ISRAEL
Haifa, Sunligth Ltd., Rehovot, (I.Y.), ISRAEL
Geriatric Department, Western Galilee Hospital, Naharyia (L.D.), ISRAEL
Address correspondence to: Sophia Ish-Shalom, M.D., Metabolic Bone Diseases Unit, Rambam Medical Center, P.O.B. 9602, 31096 Haifa, ISRAEL. E-mail: s_ish_shalom{at}rambam.health.gov.il
Background: Lactose intolerance (LI) is a common enzymatic insufficiency, manifesting by poor tolerance of dairy products, leading to low calcium intake and poor calcium absorption from dairy products. These changes might lead to an impairment of bone metabolism [1].
Objectives: To evaluate the impact of LI on quantitative bone parameters in axial and appendicular skeletal sites. To assess the impact of calcium intake from dairy and non-dairy nutritional sources, calcium regulating hormones and bone turnover on quantitative bone parameters in LI patients.
Methods: We evaluated calcium intake and bone status in sixty-six patients with LI, 49 women and 17 men, aged 20 to 78. Bone mass was assessed at the lumbar spine (LS), total hip (TH) and femoral neck (FN) by dual-energy x-ray absorptiometry (DEXA) and at the radius, tibia, phalanx by quantitative ultrasound. Serum calcium, albumin, inorganic phosphate, calcium regulating hormones and markers of bone turnover were evaluated.
Results: Total daily calcium intake was below the recommended by the American Dietetic Association [2] in all study participants (mean 692 mg/day ± 162). Elevated level of urinary deoxypyridinoline crosslinks (DPD) was observed in 63 (96%) patients and was negatively correlated with total daily calcium intake (r = -0.998, p = 0.025) and with nondairy calcium intake (r = -0.34, p = 0.015). Parathyroid hormone (PTH) level in the upper third of normal range (4565 ng/L) was observed in 11 (17%) patients. Parathyroid hormone (PTH) was inversely correlated with total calcium intake (r = -0.4, p = 0.001), dairy calcium intake (r = -0.83, p = 0.05), non-dairy calcium intake (r = -0.29, p = 0.043), 25OHD3 serum level (r = -0.3, p = 0.007) and positively correlated with bone turnover markers (deoxypyridinoline crosslinks [DPD], r = 0.36, p = 0.01 and bone specific alkaline phosphatase [BSAP] r = 0.36, p = 0.01). Decrease in quantitative bone parameters compared to age-matched controls was observed in the axial and in the appendicular skeleton in men and in postmenopausal women: mean z-score for LS -0.87 ± 0.22 and -1.32 ± 0.65, p = 0.004 and 0.015, tibia -1.15 ± 0.53 and -0.44 ± 0.044, p < 0.001 and 0.27, phalanx -0.98 ± 0.22 and -0.52 ± 0.98, p < 0.001. We observed decrease in bone mass in patients with serum PTH in the upper tertile of normal range in the FN (z-score -0.57 ± 0.6 versus -0.03 ± 0.9, p = 0.025), TH (-0.51 ± 0.96 versus 0.04 ± 0.9, p = 0.05) and radius (-1.84 ± 0.27 versus -0.07 ± 1.61, p = 0.025, respectively). z-scores in FN and TH positively correlated with serum 25OHD3 level (r = 0.31, 0.29; p = 0.014, 0.019). In postmenopausal women serum 25OHD3 level correlated also with LS z-scores (r = 0.52, p = 0.004); FN and TH z-scores negatively correlated with DPD level (r = -0.51, p = 0.02 and r = -0.55, p = 0.04).
Conclusion: LI state may lead to increased bone turnover and decreased bone mass especially in men and postmenopausal women. Impaired vitamin D status and low calcium intake may be deleterious to bone in this condition.
Key words: lactase deficiency, bone density, calcium intake
This article has been cited by other articles:
![]() |
H. Y. Lovelace and S. I. Barr Diagnosis, Symptoms, and Calcium Intakes of Individuals with Self-Reported Lactose Intolerance J. Am. Coll. Nutr., February 1, 2005; 24(1): 51 - 57. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |